Mirum appoints Dr. Rob Myers as chief medical officer
Mirum Pharmaceuticals appointed Dr. Rob Myers as CMO as it prepares pivotal clinical readouts and regulatory filings next year for HDV, FOP and cholestatic pruritus, while expanding its rare-disease pipeline and applying AI to R&D.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.